237 related articles for article (PubMed ID: 18452176)
1. Colloidal soft matter as drug delivery system.
Bonacucina G; Cespi M; Misici-Falzi M; Palmieri GF
J Pharm Sci; 2009 Jan; 98(1):1-42. PubMed ID: 18452176
[TBL] [Abstract][Full Text] [Related]
2. Development and characterization of colloidal soft nano-carriers for transdermal delivery and bioavailability enhancement of an angiotensin II receptor blocker.
Hathout RM; Elshafeey AH
Eur J Pharm Biopharm; 2012 Oct; 82(2):230-40. PubMed ID: 22820090
[TBL] [Abstract][Full Text] [Related]
3. Past and future evolution in colloidal drug delivery systems.
Boyd BJ
Expert Opin Drug Deliv; 2008 Jan; 5(1):69-85. PubMed ID: 18095929
[TBL] [Abstract][Full Text] [Related]
4. Dermal peptide delivery using colloidal carrier systems.
Goebel A; Neubert RH
Skin Pharmacol Physiol; 2008; 21(1):3-9. PubMed ID: 17912018
[TBL] [Abstract][Full Text] [Related]
5. Chapter 10 - Solid lipid nanoparticles and microemulsions for drug delivery The CNS.
Gasco MR; Priano L; Zara GP
Prog Brain Res; 2009; 180():181-92. PubMed ID: 20302835
[TBL] [Abstract][Full Text] [Related]
6. Drug delivery systems for differential release in combination therapy.
Zhang H; Wang G; Yang H
Expert Opin Drug Deliv; 2011 Feb; 8(2):171-90. PubMed ID: 21226651
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in topical delivery of proteins and peptides mediated by soft matter nanocarriers.
Witting M; Obst K; Friess W; Hedtrich S
Biotechnol Adv; 2015 Nov; 33(6 Pt 3):1355-69. PubMed ID: 25687276
[TBL] [Abstract][Full Text] [Related]
8. Encapsulation, protection, and release of hydrophilic active components: potential and limitations of colloidal delivery systems.
McClements DJ
Adv Colloid Interface Sci; 2015 May; 219():27-53. PubMed ID: 25747522
[TBL] [Abstract][Full Text] [Related]
9. [Pharmaceutical applications of the zeta potential--use in characterization of colloidal drug carriers].
Le Roy Boehm AL; Fessi H
J Pharm Belg; 2000; 55(2):40-8. PubMed ID: 10842925
[TBL] [Abstract][Full Text] [Related]
10. Microemulsions: applications in transdermal and dermal delivery.
Date AA; Patravale VB
Crit Rev Ther Drug Carrier Syst; 2007; 24(6):547-96. PubMed ID: 18298390
[TBL] [Abstract][Full Text] [Related]
11. Pharmaceutical development and regulatory considerations for nanoparticles and nanoparticulate drug delivery systems.
Narang AS; Chang RK; Hussain MA
J Pharm Sci; 2013 Nov; 102(11):3867-82. PubMed ID: 24037829
[TBL] [Abstract][Full Text] [Related]
12. Delivery systems for biopharmaceuticals. Part II: Liposomes, Micelles, Microemulsions and Dendrimers.
Silva AC; Lopes CM; Lobo JM; Amaral MH
Curr Pharm Biotechnol; 2015; 16(11):955-65. PubMed ID: 26278524
[TBL] [Abstract][Full Text] [Related]
13. Niosomes vs microemulsions: new carriers for topical delivery of Capsaicin.
Tavano L; Alfano P; Muzzalupo R; de Cindio B
Colloids Surf B Biointerfaces; 2011 Oct; 87(2):333-9. PubMed ID: 21684725
[TBL] [Abstract][Full Text] [Related]
14. Novel Ocular Drug Delivery Systems: An Update on Microemulsions.
Üstündağ Okur N; Çağlar EŞ; Siafaka PI
J Ocul Pharmacol Ther; 2020; 36(6):342-354. PubMed ID: 32255728
[TBL] [Abstract][Full Text] [Related]
15. Lipid nanoparticles for the delivery of poorly water-soluble drugs.
Bunjes H
J Pharm Pharmacol; 2010 Nov; 62(11):1637-45. PubMed ID: 21039547
[TBL] [Abstract][Full Text] [Related]
16. Development and evaluation of colloidal modified nanolipid carrier: application to topical delivery of tacrolimus, Part II--in vivo assessment, drug targeting, efficacy, and safety in treatment for atopic dermatitis.
Pople PV; Singh KK
Eur J Pharm Biopharm; 2013 May; 84(1):72-83. PubMed ID: 23246619
[TBL] [Abstract][Full Text] [Related]
17. Emulsion-based delivery systems for lipophilic bioactive components.
McClements DJ; Decker EA; Weiss J
J Food Sci; 2007 Oct; 72(8):R109-24. PubMed ID: 17995616
[TBL] [Abstract][Full Text] [Related]
18. Using principal component analysis in studying the transdermal delivery of a lipophilic drug from soft nano-colloidal carriers to develop a quantitative composition effect permeability relationship.
Hathout RM
Pharm Dev Technol; 2014 Aug; 19(5):598-604. PubMed ID: 23879693
[TBL] [Abstract][Full Text] [Related]
19. Microemulsions--modern colloidal carrier for dermal and transdermal drug delivery.
Heuschkel S; Goebel A; Neubert RH
J Pharm Sci; 2008 Feb; 97(2):603-31. PubMed ID: 17696162
[TBL] [Abstract][Full Text] [Related]
20. Novel strategies for the formulation and processing of poorly water-soluble drugs.
Göke K; Lorenz T; Repanas A; Schneider F; Steiner D; Baumann K; Bunjes H; Dietzel A; Finke JH; Glasmacher B; Kwade A
Eur J Pharm Biopharm; 2018 May; 126():40-56. PubMed ID: 28532676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
